Yokogawa Insilico Biotechnology
Delivering enterprise digital twins for faster time to market, reduced costs and enhanced quality of therapeutics.Smart biofactories for better therapies
Smart biofactories for better therapies. Insilico aims to deliver outstanding results to customers and shareholders by acting in an agile and transparent way. We value differing opinions, cultures and backgrounds, as diverse teams are a key success factor. Continuous improvement is paramount to becoming the leading supplier of innovative predictive Digital Twins for bio-pharmaceutical companies
Cell Line Engineering Bioprocess Engineering Metabolic modeling